Deletion of Regnase-1 was sufficient to improve T-cell expansion, functionality, and persistence, leading to enhanced anti-tumor responses in mice (Wei et al, 2019; Zheng et al, 2021; Mai et al, 2023; Raj et al, 2023). This evidence concerns the gene ZC3H12A and neoplasm.